Navigation Links
First articles now live on F1000 Research
Date:7/16/2012

F1000 Research's revolutionary vision has been inspiring debate across the scientific community since the beginning of the year. Its informed contribution to the wider discussion about open access publishing has advanced to a new level this week with the publication of its first few articles (please see http://f1000research.com/articles). A call for papers has been issued and further articles will be published on the current consultation site while the publishing model and editorial systems are fine-tuned in preparation for a complete launch later this year.

F1000 Research challenges traditional models by defining new standards for speed, peer review, and the sharing of data. Features include:

  • immediate publication
  • rapid, formal, and completely open peer review process post-publication
  • acceptance of null/negative and replication/refutation findings
  • publication and refereeing of datasets as separate data articles

All submissions to F1000 Research will go through a fast initial review by the in-house editorial team who will check to ensure that articles are sensible, intelligible, and written in good English. Each article will then be published with the status 'awaiting peer review'.

On publication, the article will be sent to 3-5 expert referees who will be asked to state, firstly, whether the work seems scientifically sound. These responses will be displayed immediately alongside the article and its citation, and will be updated as new referee responses arrive. Subsequently, referees will be asked to provide more detailed comments and feedback, which will also be displayed with the article. Authors will be encouraged to revise their articles in response to referee comments and each article version will be citable with its own DOI. A novel article citation mechanism, developed with the assistance of the F1000 Research Advisory Panel and the leading indexers, will capture the article version number and referee status.

Once an article receives two positive referee responses, it will be indexed. Scopus, Embase and Google Scholar have agreed to index F1000 Research content immediately, and discussions aimed at putting in place similar arrangements with other major indexers are ongoing. Should an article receive no positive reviews it will not be indexed and will be removed from the default search on the site.

These first articles showcase a novel inline data viewer that has been developed in conjunction with figshare (http://figshare.com). It enables readers to preview data files without having to download them, and allows all readers, even those without suitable viewers for these files, to view the datasets in a 'friendly' format.

All publishing charges are waived for 2012. Moderate author processing charges will be introduced in 2013. More information can be found at: http://f1000research.com.

Commenting on this significant development, Dr Rebecca Lawrence, Publisher for F1000 Research, said: "We are very excited to announce the publication of our first articles on F1000 Research. We would like to thank everyone who has helped us get this far, not least our Advisory Panel and Editorial Board. The discussion continues on Twitter at @F1000Research, and we invite the research community to join us as the project takes shape."

More than 200 of the most eminent names in biology and medicine have joined the international Advisory Panel (see all members at: http://f1000research.com/advisory-panel), and more than 1000 global experts sit on the newly formed Editorial Board (see http://f1000research.com/editorial-board). The project has received great support from the wider scientific community, sparking extensive discussions about the future of scholarly publishing.


'/>"/>

Contact: Eleanor Howell
press@f1000.com
44-207-631-9129
Faculty of 1000: Biology and Medicine
Source:Eurekalert

Related biology news :

1. Kessler Foundation implements Ekso Bionics first commercial robotic exoskeleton
2. Research reveals first evidence of hunting by prehistoric Ohioans
3. First model of how buds grow into leaves
4. American College of Rheumatology releases first classification criteria for polymyalagia rheumatica
5. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
6. First complete full genetic map of promising energy crop
7. FirstMark Announces New Hire Jay Houtman as Southeast Regional Sales Manager
8. FirstMark Exhibiting at the Inaugural Atlanta Clinical Cardiology Update
9. New technology tracks sparrow migration for first time from California to Alaska
10. First mass extinction linked to marine anoxia
11. Scientists complete first-ever emperor penguin count from space
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)...  On April 6-7, 2017, Sequencing.com will host the ... hackathon at Microsoft,s headquarters in Redmond, Washington ... developing health and wellness apps that provide a unique, ... is the first hackathon for personal genomics and ... in the genomics, tech and health industries are sending ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are the ... million people each year. Especially those living in larger cities are affected by air ... one of the most pollution-affected countries globally - decided to take action. , “I ...
(Date:10/11/2017)... ... 11, 2017 , ... Singh Biotechnology today announced that the ... its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single ... the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation of ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder ... local San Diego Rotary Club. The event entitled “Stem Cells and ... had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: ...
Breaking Biology Technology: